Effects of histidine and n-acetylcysteine on doxorubicin-induced cardiomyopathy in rats

Cardiovascular Toxicology

Volumn 14, Issue 2, 2014, Pages 153-161

  Farshid, Amir Abbas ^a   Tamaddonfard, Esmaeal ^a   Simaee, Naeime ^a   Mansouri, Sanam ^a   Najafi, Sima ^a   Asri Rezaee, Siamak ^a   Alavi, Hossein ^a  

^a URMIA UNIVERSITY   (Iran)

Author keywords

Doxorubicin; ECG; Heart; Histidine; N acetylcysteine; Rats

Indexed keywords

ACETYLCYSTEINE; CREATINE KINASE; DOXORUBICIN; HISTIDINE; LACTATE DEHYDROGENASE; MALONALDEHYDE; BIOLOGICAL MARKER; SCAVENGER;

ANIMAL EXPERIMENT; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOXORUBICIN INDUCED CARDIOMYOPATHY; ELECTROCARDIOGRAPHY; HEART PROTECTION; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT RESPONSE; ANIMAL; BLOOD; CARDIOMYOPATHIES; CELL PROTECTION; CHEMICALLY INDUCED; CONVALESCENCE; DISEASE MODEL; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECTS; HEART MUSCLE; HEART RATE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ACETYLCYSTEINE; ANIMALS; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CREATINE KINASE; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FREE RADICAL SCAVENGERS; HEART RATE; HISTIDINE; L-LACTATE DEHYDROGENASE; MALE; MALONDIALDEHYDE; MYOCARDIUM; RATS, WISTAR; RECOVERY OF FUNCTION;

EID: 84902356017     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-013-9239-6     Document Type: Article

References (50)

1. Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004). Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacological Review, 56, 185-229. (Pubitemid 38720829)
2. Singal, P. K., & Iliskovic, N. (1998). Doxorubicin-induced cardiomyopathy. New England Journal of Medicine, 339, 900-905. (Pubitemid 28446849)
3. Simunek, T., Sterba, M., Popelova, O., Adancova, M., Hrdina, R., & Gersl, V. (2009). Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacological Reports, 91, 154-171.
4. Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijins, H. J., & Moens, A. L. (2012). Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology, 52, 1213-1225.
5. Volkova, M., & Russell, R, 3rd. (2011). Anthracycline cardiotoxicity: Prevalence, pathogenesis and treatment. Current Cardiology Reviews, 7, 214-220.
6. Ito, T., Muraoka, S., Takahashi, K., Fujio, Y., Schaffer, W., & Azuma, J. (2009). Beneficial effects of taurine treatment against doxorubicin-induced cardiotoxicity in mice. Advances in Experimental Medicine and Biology, 643, 65-74.
7. Todorova, V. K., Kaufmann, Y., Hennings, L., & Kimberg, V. S. (2010). Oral glutamine protects against acute doxorubicininduced cardiotoxicity in tumor-bearing rats. Journal of Nutrition, 140, 44-48.
8. Farshid, A. A., Tamaddonfard, E., Belasius, M. S., & Hamzeh-Gooshchi, N. (2009). Histopathological comparison of the effects of histidine and ketotifen in a rat model of colitis. Bulletin of the Veterinary Institute in Pulawy, 53, 795-800.
9. Farshid, A. A., Tamaddonfard, E., & Morvaridi, A. (2011). Effects of histidine and dexamethasone on the local inflammation induced by histamine in rats. Veterinary Research Forum, 2, 31-36.
10. Farshid, A. A., Tamaddonfard, E., & Ranjbar, S. (2013). Oral administration of vitamin C and histidine attenuate cyclophosphamide-induced hemorrhagic cystitis in rats. Indian Journal of Pharmacology, 45, 126-129.
11. Farshid, A. A., Tamaddonfard, E., & Yahyaee, F. (2010). Effects of histidine and N-acetylcysteine on diclofenac-induced antiinflammatory response in acute inflammation in rats. Indian Journal of Experimental Biology, 48, 1136-1142.
12. Tamaddonfard, E., & Rahimi, S. (2004). Central effect of histamine and peripheral effect of histidine on the formalin-induced pain responses in mice. Clinical and Experimental Pharmacology and Physiology, 31, 518-522. (Pubitemid 39095033)
13. Wade, A. M., & Tucker, H. N. (1998). Antioxidant characteristics of L-histidine. The Journal of Nutritional Biochemistry, 9, 308-315. (Pubitemid 28318264)
14. Obata, T., Aomine, M., & Yamanaka, Y. (1999). Protective effect of histidine on iron (II)-induced hydroxyl radical generation in rat hearts. Journal of Physiology (Paris), 93, 216-218.
15. Kelly, G. S. (1998). Clinical application of N-acetylcysteine. Alternative Medicine Review, 3, 114-127.
16. Doroshow, J. H., Locker, G. Y., Ifrim, I., & Myers, C. E. (1981). Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. The Journal of Clinical Investigation, 68, 1053-1064. (Pubitemid 11023534)
17. Arica, V., Demir, I. H., Tutanc, M., Barsarslan, F., Arica, S., Karcoiglu, M., et al. (2013). N-acetylcysteine prevents doxorubicin-induced cardiotoxicity in rats. Human and Experimental Toxicology, 32, 655-661.
18. Singh, D. K., & Lippman, S. M. (1998). Cancer chemoprevention part 1: Retinoids and carotenoids and other classic antioxidants. Oncology, 12, 1643-1660.
19. Bayne, K. (1996). Revised, guide for the care and use of laboratory animals. American physiological society. Physiologist, 39, 208-211.
20. Clark, J. D., Gebhart, G. F., Conder, J. C., Keeling, M. E., & Kohn, D. F. (1997). Special report: The 1996 guide for the care and use of laboratory animals. Institute of Laboratory Animals Research Journal, 38, 41-48.
21. Xin, Y. F., Zhou, G. L., Deng, Z. Y., Chen, Y. X., Wu, Y. G., Xu, P. S., et al. (2007). Protective effect of Lycium barbarum on doxorubicin-induced cardiotoxicity. Phytotherapy Research, 21, 1020-1024.
22. Kolarovic, J., Popovic, M., Zlinska, J., Trivic, S., & Vojnovic, M. (2010). Antioxidant activity of celery and parseley in rats treated with doxorubicin. Molecules, 15, 6193-6204.
23. Tariq, M., Morais, C., Soki, S., Al Sulaiman, M., & Al Khader, A. (1999). N-acetylcysteine attenuates cyclosporine-induced nephrotoxicity in rats. Nephrology, Dialysis, Transplantation, 14, 923-929. (Pubitemid 29155148)
24. Kakulavarapu, V., Rao, R., Reddy, P. V. B., Tong, X., & Norenberg, M. D. (2010). Brain edema in acute liver failure: Inhibition by L-histidine. American Journal of Pathology, 176, 1400-1408.
25. Farraj, A. K., Hazari, M. S., & Cascio, W. E. (2011). The utility of the small rodent electrocardiogram in toxicity. Toxicological Sciences, 121, 11-30.
26. Ammar, E.-S. M., Said, S. A., El-Damarawy, S. L., & Suddek, G. M. (2013). Cardioprotective effect of grape-seed proanthocyanidins on doxorubicin-induced cardiac toxicity in rats. Pharmaceutical Biology, 51, 339-344.
27. Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay of lipid peroxidase in normal tissue by thiobarbituric acid reaction. Analytical Biochemistry, 95, 351-358. (Pubitemid 9194347)
28. Jensen, R. A., Acton, E. M., & Peters, J. H. (1984). Electrocardiographic and transmembrane potential effects of 5-iminodaunorubicin in the rat. Cancer Research, 44, 4030-4039. (Pubitemid 14041633)
29. Shan, S., Mohan, M. M., Kasture, S., Sanna, C., & Maxia, A. (2009). Protective effect of Ephedra nebrodensis on doxorubicin-induced cardiotoxicity in rats. Iranian Journal of Pharmacology and Therapeutics, 8, 61-66.
30. van Acker, S. A., Kramer, K., Voest, E. E., Grimbergen, J. A., Zhang, J., van der Vijgh, W. J., et al. (1996). Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice. A new model to test potential protectors. Cancer Chemotherapy and Pharmacology, 38, 95-101.
31. Dudka, J., Gieroba, R., Korga, A., Burdan, F., Matysiak, W., Jodlowska-Jedrich, B., et al. (2012). Different effects of resveratrol on dose-related doxorubicin-induced heart and liver toxicity. Evidence Based Complementary and Alternative Medicine, 2012, 606183. doi:10.1155/2012/606183.
32. Abd Elbaky, A. N., Ali, A. A., & Ahmed, R. A. (2010). Cardioprotective effect of simvastatin on doxorubicin-induced oxidative cardiotoxicity in rats. Journal of Basic and Applied Sciences, 6, 29-38.
33. Yagamura, M., Fadillioglu, E., & Erdogan, H. (2003). Erdosteine prevents doxorubicin-induced cardiotoxicity in rats. Pharmacological Research, 48, 377-382. (Pubitemid 36945336)
34. Xu, M. F., Tang, P. L., Qian, Z. M., & Ashraf, M. (2001). Effects by doxorubicin on the myocardium are mediated by oxygen free radicals. Life Sciences, 68, 889-901. (Pubitemid 32168065)
35. Koti, B. C., Vishwanathswamy, A. H. M., Wagawade, J., & Thippeswamy, A. H. M. (2009). Cardioprotective effect of lipistat against doxorubicin induced myocardial toxicity in albino rats. Indian Journal of Experimental Biology, 47, 41-46.
36. Mokni, M., Hamlaoui-Guesmi, S., Amir, M., Marzuki, L., Limam, F., & Aouan, E. (2012). Grape seed and skin extract protects against acute chemotherapy toxicity induced by doxorubicin in rat heart. Cardiovascular Toxicology, 12, 158-165.
37. Lebrecht, D., Geist, A., Ketelsen, U. P., Haberstroh, J., Setzer, B., & Walker, U. A. (2007). Dexrazoxane prevents doxorubicininduced long-term cardiotoxicity and protect myocardial mitochondria from genetic and functional lesions in rats. British Journal of Pharmacology, 151, 771-778. (Pubitemid 47075325)
38. Moore, K., & Roberts, L. J. (1998). Measurement of lipid peroxidation. Free Radical Research, 28, 659-671. (Pubitemid 28454258)
39. Chatterjee, A., Zhang, J., Honbo, N., & Karliner, J. S. (2010). Doxorubicin cardiotoxicity. Cardiology, 115, 155-162.
40. Lee, Y. T., Hsu, C. C., Lin, M. H., Liu, K. S., & Yin, M. C. (2005). Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. European Journal of Pharmacology, 513, 145-150.
41. Li, S. Q., Zhao, G., Li, J., & Qian, W. (1998). Effect of histidine on myocardial mitochondria and platelet aggregation during thrombic cerebral ischemia in rats. Zhongguo Yao Li Xu Bao, 19, 493-496. (Pubitemid 28423603)
42. Cai, Q., Takemura, G., & Ashraf, M. (1995). Antioxidative properties of histidine and its effect on myocardial injury during ischemia/reperfusion in isolated rat heart. Journal of Cardiovascular Pharmacology, 25, 147-155.
43. Villani, F., Galimberti, M., Monti, E., Piccinini, F., Lanza, E., Rozza, A., et al. (1990). Effect of glutathione and N-acetylcysteine on in vitro and in vivo cardiac toxicity of doxorubicin. Free Radical Research Communications, 11, 145-151.
44. Powell, S. R., & McCay, P. B. (1988). Inhibition of doxorubicin-initiated membrane damage by N-acetylcysteine: possible mediation by a thiol-dependent, cytosolic inhibitor of lipid peroxidation. Toxicology and Applied Pharmacology, 96, 175-184. (Pubitemid 19011144)
45. Park, E. S., Kim, S. D., Lee, M. H., Lee, H. S., Lee, I. S., Sung, J. K., et al. (2003). Protective effect of N-acetylcysteine and selenium against doxorubicin toxicity in rats. Journal of Veterinary Science, 4, 129-136.
46. Kockar, M. C., Naziroglu, M., Celik, O., Tola, H. T., Bayram, D., & Koyu, A. (2010). N-acetylcysteine modulates doxorubicin-induced oxidative stress and antioxidant vitamin concentrations in liver of rats. Cell Biochemistry and Function, 28, 673-677.
47. Dobrzynska, I., Skrzydlewska, E., Kasacka, I., & Figaszewiski, Z. (2000). Protective effect of N-acetylcysteine on rat liver cell membrane during methanol intoxication. Journal of Pharmacy and Pharmacology, 52, 547-552. (Pubitemid 30319159)
48. Peterson, J. W., Boldogh, I., Popov, P. L., Saini, S. S., & Chopra, A. K. (1998). Anti-inflammatory and antisecretory potential of histidine in salmonella challenged mouse small intestine. Laboratory Investigation, 78, 523-534. (Pubitemid 28246976)
49. Lamson, D. W., & Brignall, M. S. (1999). Antioxidants in cancer therapy: Their actions and interactions with oncologic therapies. Alternative Medicine Review, 4, 304-329. (Pubitemid 29526338)
50. Kalaiselvi, P., Pragasam, V., Chinnikishnan, S., Veera, C. K., Sundarapandiyan, R., & Varalakshmi, P. (2005). Counteracting adriamycin-induced oxidative stress by administration of N-acetylcysteine and vitamin E. Clinical Chemistry and Laboratory Medicine, 43, 834-840. (Pubitemid 41461158)